Mimedx (MDXG) Net Cash Flow (2011 - 2026)
Mimedx recorded quarterly Net Cash Flow of -$6.3 million in Q1 2026, down 126.41% quarter-over-quarter from $24.0 million in Q4 2025, and down 415.04% year-over-year from $2.0 million in Q1 2025.
Mimedx's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$6.3 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 415.04% year-over-year to -$6.3 million; the TTM figure through Mar 2026 stood at $53.3 million (down 9.4% YoY), while the FY2025 annual figure was $61.7 million, up 164.31% from the prior year.
- Net Cash Flow came in at -$6.3 million for Q1 2026 at Mimedx, down from $24.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $24.0 million in Q4 2025 to a low of -$33.5 million in Q1 2024.
- A 5-year average of $4.9 million and a median of $2.7 million in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow tumbled 1316.09% in 2022 and surged 1879.07% in 2024, its largest moves.
- Mimedx's Net Cash Flow stood at $2.7 million in 2022, then slumped by 68.5% to $836000.0 in 2023, then soared by 1879.07% to $16.5 million in 2024, then soared by 45.29% to $24.0 million in 2025, then sank by 126.41% to -$6.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$6.3 million, $24.0 million, and $23.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -6.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.35 Mn |
| Mar 31, 2026 | -6.35 Mn |
| Dec 31, 2025 | 24.04 Mn |
| Dec 31, 2025 | 24.04 Mn |
| Sep 30, 2025 | 23.21 Mn |
| Sep 30, 2025 | 23.21 Mn |
| Jun 30, 2025 | 12.44 Mn |
| Jun 30, 2025 | 12.44 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Dec 31, 2024 | 16.55 Mn |
| Dec 31, 2024 | 16.55 Mn |
| Sep 30, 2024 | 18.83 Mn |
| Sep 30, 2024 | 18.83 Mn |
| Jun 30, 2024 | 21.48 Mn |
| Jun 30, 2024 | 21.48 Mn |
| Mar 31, 2024 | -33.51 Mn |
| Mar 31, 2024 | -33.51 Mn |
| Dec 31, 2023 | 836,000.00 |
| Dec 31, 2023 | 836,000.00 |
| Sep 30, 2023 | 12.51 Mn |
| Sep 30, 2023 | 12.51 Mn |
| Jun 30, 2023 | 7.43 Mn |
| Jun 30, 2023 | 7.43 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Dec 31, 2022 | 2.65 Mn |
| Dec 31, 2022 | 2.65 Mn |
| Sep 30, 2022 | 715,000.00 |
| Sep 30, 2022 | 715,000.00 |
| Jun 30, 2022 | -3.17 Mn |
| Jun 30, 2022 | -3.17 Mn |
| Mar 31, 2022 | -11.41 Mn |
| Mar 31, 2022 | -11.41 Mn |
| Dec 31, 2021 | -11.42 Mn |
| Dec 31, 2021 | -11.42 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 261,000.00 |
| Jun 30, 2021 | 261,000.00 |
| Mar 31, 2021 | -11.07 Mn |
| Mar 31, 2021 | -11.07 Mn |
| Dec 31, 2020 | -13.78 Mn |
| Dec 31, 2020 | -13.78 Mn |
| Sep 30, 2020 | 61.41 Mn |
| Sep 30, 2020 | 61.41 Mn |
| Jun 30, 2020 | -5.34 Mn |
| Jun 30, 2020 | -5.34 Mn |
| Mar 31, 2020 | -15.54 Mn |
| Mar 31, 2020 | -15.54 Mn |
| Dec 31, 2019 | -25.05 Mn |
| Dec 31, 2019 | -25.05 Mn |
| Sep 30, 2019 | -2.81 Mn |
| Sep 30, 2019 | -2.81 Mn |
| Jun 30, 2019 | 68.55 Mn |
| Jun 30, 2019 | 68.55 Mn |
| Mar 31, 2019 | -16.74 Mn |
| Mar 31, 2019 | -16.74 Mn |
| Dec 31, 2018 | 63,000.00 |
| Dec 31, 2018 | 63,000.00 |
| Sep 30, 2018 | 720,000.00 |
| Sep 30, 2018 | 720,000.00 |
| Jun 30, 2018 | 17.88 Mn |
| Jun 30, 2018 | 17.88 Mn |
| Mar 31, 2018 | -1.02 Mn |
| Mar 31, 2018 | -1.02 Mn |
| Dec 31, 2017 | -4.98 Mn |
| Dec 31, 2017 | -4.98 Mn |
| Sep 30, 2017 | -11.01 Mn |
| Sep 30, 2017 | -11.01 Mn |
| Jun 30, 2017 | 16.61 Mn |
| Jun 30, 2017 | 16.61 Mn |
| Mar 31, 2017 | -3.47 Mn |
| Mar 31, 2017 | -3.47 Mn |
| Dec 31, 2016 | 14.17 Mn |
| Dec 31, 2016 | 14.17 Mn |
| Sep 30, 2016 | -5.47 Mn |
| Sep 30, 2016 | -5.47 Mn |
| Jun 30, 2016 | 8.69 Mn |
| Jun 30, 2016 | 8.69 Mn |
| Mar 31, 2016 | -13.37 Mn |
| Mar 31, 2016 | -13.37 Mn |
| Dec 31, 2015 | -12.59 Mn |
| Dec 31, 2015 | -12.59 Mn |
| Sep 30, 2015 | 2.47 Mn |
| Sep 30, 2015 | 2.47 Mn |
| Jun 30, 2015 | -95,000.00 |
| Jun 30, 2015 | -95,000.00 |
| Mar 31, 2015 | -7.89 Mn |
| Mar 31, 2015 | -7.89 Mn |
| Dec 31, 2014 | -670,000.00 |
| Dec 31, 2014 | -670,000.00 |
| Sep 30, 2014 | 8.01 Mn |
| Sep 30, 2014 | 8.01 Mn |
| Jun 30, 2014 | -3.77 Mn |
| Jun 30, 2014 | -3.77 Mn |
| Mar 31, 2014 | -1.06 Mn |
| Mar 31, 2014 | -1.06 Mn |
| Dec 31, 2013 | 38.02 Mn |
| Dec 31, 2013 | 38.02 Mn |
| Sep 30, 2013 | 1.87 Mn |
| Sep 30, 2013 | 1.87 Mn |
| Jun 30, 2013 | -1.53 Mn |
| Jun 30, 2013 | -1.53 Mn |
| Mar 31, 2013 | -1.03 Mn |
| Mar 31, 2013 | -1.03 Mn |
| Dec 31, 2012 | -867,900.00 |
| Dec 31, 2012 | -867,900.00 |
| Sep 30, 2012 | 4.97 Mn |
| Sep 30, 2012 | 4.97 Mn |
| Jun 30, 2012 | -366,572.00 |
| Jun 30, 2012 | -366,572.00 |
| Mar 31, 2012 | -1.09 Mn |
| Mar 31, 2012 | -1.09 Mn |
| Dec 31, 2011 | 3.48 Mn |
| Dec 31, 2011 | 3.48 Mn |
| Sep 30, 2011 | -977,158.00 |
| Sep 30, 2011 | -977,158.00 |
| Jun 30, 2011 | 593,817.00 |
| Jun 30, 2011 | 593,817.00 |
| Mar 31, 2011 | -320,389.00 |
| Mar 31, 2011 | -320,389.00 |